CARM1 and BAF155: an example of how chromatin remodeling factors can be relocalized and contribute to cancer

被引:0
|
作者
Olafur A Stefansson
Manel Esteller
机构
[1] Bellvitge Biomedical Research Institute (IDIBELL),Cancer Epigenetics and Biology Program (PEBC)
[2] Av. Gran Via de L’Hospitalet 199-203,Cancer Research Laboratory
[3] L’Hospitalet del Llobregat,Department of Physiological Sciences II
[4] Faculty of Medicine,undefined
[5] University of Iceland,undefined
[6] School of Medicine,undefined
[7] University of Barcelona,undefined
[8] Institució Catalana de Recerca i Estudis Avançats (ICREA),undefined
来源
关键词
Chromatin Remodel; Arginine Residue; MCF7 Breast Cancer Cell; Recurrent Mutation; Methyltransferase Activity;
D O I
暂无
中图分类号
学科分类号
摘要
In a recent article, Wang and colleagues reported the discovery of a mechanism by which CARM1 regulates the genomic localization of BAF155 (a SWI/SNF subunit involved in chromatin remodeling) through post-translational methylation at R1064 arginine residues. This modification leads to the relocalization of BAF155-containing SWI/SNF complexes to regions containing genes involved in the Myc oncogenic pathway. The results presented are evidence that these interactions constitute a mechanism by which the BAF155 chromatin remodeling factor contributes to cancer.
引用
收藏
相关论文
共 9 条
  • [1] CARM1 and BAF155: an example of how chromatin remodeling factors can be relocalized and contribute to cancer
    Stefansson, Olafur A.
    Esteller, Manel
    BREAST CANCER RESEARCH, 2014, 16 (03):
  • [3] CARM1 methylates BAF155 and perturbs chromatin remodeling machinery to enhance tumor progression
    Wang, Lu
    Zhao, Zibo
    Meyer, Mark
    Pike, Wesley J.
    Xu, Wei
    CANCER RESEARCH, 2013, 73
  • [4] CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis
    Wang, Lu
    Zhao, Zibo
    Meyer, Mark B.
    Saha, Sandeep
    Yu, Menggang
    Guo, Ailan
    Wisinski, Kari B.
    Huang, Wei
    Cai, Weibo
    Pike, J. Wesley
    Yuan, Ming
    Ahlquist, Paul
    Xu, Wei
    CANCER CELL, 2014, 25 (01) : 21 - 36
  • [5] CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis (vol 25, pg 21, 2014)
    Wang, Lu
    Zhao, Zibo
    Meyer, Mark B.
    Saha, Sandeep
    Yu, Menggang
    Guo, Ailan
    Wisinski, Kari B.
    Huang, Wei
    Cai, Weibo
    Pike, J. Wesley
    Yuan, Ming
    Ahlquist, Paul
    Xu, Wei
    CANCER CELL, 2016, 30 (01) : 179 - 180
  • [6] Characterization of the loss of BAF155 of the SWI/SNF chromatin remodeling complex in human cancer cell lines
    Delbove, Jessica N.
    Stroebeck, Matthew W.
    Knudsen, Erik S.
    Wang, Weidong
    Archer, Trevor K.
    Chen, Jianguang
    Weissman, Bernard E.
    CANCER RESEARCH, 2006, 66 (08)
  • [7] CARM1-mediated BAF155 methylation promotes metastasis and is targetable to reduce disparate mortality in triple negative breast cancer
    Kim, Eui-Jun
    Liu, Peng
    Wang, Yidan
    Ong, Irene M.
    Xu, Wei
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (01) : 260 - 261
  • [8] CARM1 hypermethylates the NuRD chromatin remodeling complex to promote cell cycle gene expression and breast cancer development
    Chen, Xue
    Huang, Ming-feng
    Fan, Da-meng
    He, Yao-hui
    Zhang, Wen-juan
    Ding, Jian-cheng
    Peng, Bing-ling
    Pan, Xu
    Liu, Ya
    Du, Jun
    Li, Ying
    Liu, Zhi-ying
    Xie, Bing-lan
    Kuang, Zhi-jian
    Yi, Jia
    Liu, Wen
    NUCLEIC ACIDS RESEARCH, 2024, 52 (12) : 6811 - 6829
  • [9] 1H, 15N, and 13C resonance assignments and secondary structure of the SWIRM domain of human BAF155, a chromatin remodeling complex component
    Moon, Sunjin
    Shin, Joon
    Lee, Dongju
    Seong, Rho H.
    Lee, Weontae
    MOLECULES AND CELLS, 2013, 36 (04) : 333 - 339